Treatment of Ultracentral Lung Tumors with Hypofractionated Radiation Therapy

被引：0
|
作者：
Nsouli, T. [1 ]
Alden, R. [1 ]
Ennis, W. [1 ]
Mix, M. [1 ]
Bogart, J. [1 ]
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
hypofractionated radiation therapy; ultracentral;
D O I：
10.1016/j.jtho.2019.08.1298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.17-24
引用
收藏
页码：S617 / S617
页数：1
相关论文
共 50 条
  • [31] Risk-Adapted Lung SBRT for Central and UltraCentral Tumors
    Lenglet, A.
    Mathieu, D.
    Campeau, M. P.
    Bahig, H.
    Vu, T.
    Roberge, D.
    Bilodeau, L.
    Filion, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E473 - E474
  • [32] Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
    Young, Kristina H.
    Baird, Jason R.
    Savage, Talicia
    Cottam, Benjamin
    Friedman, David
    Bambina, Shelly
    Messenheimer, David J.
    Fox, Bernard
    Newell, Pippa
    Bahjat, Keith S.
    Gough, Michael J.
    Crittenden, Marka R.
    PLOS ONE, 2016, 11 (06):
  • [33] Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
    Amini, Arya
    Lin, Steven H.
    Wei, Caimiao
    Allen, Pamela
    Cox, James D.
    Komaki, Ritsuko
    RADIATION ONCOLOGY, 2012, 7
  • [34] Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
    Arya Amini
    Steven H Lin
    Caimiao Wei
    Pamela Allen
    James D Cox
    Ritsuko Komaki
    Radiation Oncology, 7
  • [35] Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors
    Tekatli, H.
    Duijm, M.
    Hoop, E. Oomen-de
    Verbakel, W.
    Schillemans, W.
    Slotman, B. J.
    Nuyttens, J. J.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (03): : 738 - 747
  • [36] Clinical Outcome of Hypofractionated Radiation Therapy for Lung, Liver, and Pancreatic Cancer
    Xia, T.
    Li, H.
    Wang, J.
    Wang, Y.
    Li, P.
    Chang, D.
    Wang, J.
    Wu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S574 - S575
  • [37] Treatment of Thymic Oligometastastic or Oligoprogressive Lesions with Hypofractionated Radiation Therapy or Stereotactic Body Radiation Therapy
    Jackson, C.
    Rimner, A.
    Simone, C. B., II
    Lebow, E. S.
    Huang, J.
    Riely, G.
    Ginsberg, M.
    Pagano, A.
    Chang, J.
    Mayoral, M.
    Gomez, D. R.
    Shepherd, A. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E408 - E409
  • [38] Hypofractionated Stereotactic Body Radiation Therapy for the Definitive Treatment of Sarcoma
    Cengiz, M.
    Dauletkazin, A.
    Yildiz, F.
    Yazici, G.
    Akyol, F.
    Zorlu, F.
    Gurkaynak, M.
    Ozyigit, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E714 - E715
  • [39] An Ultracentral Lung Tumor
    Palma, David A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 651 - 651
  • [40] SBRT for Ultracentral Lung Tumors In Regard to Giuliani et al.
    Dionisi, Francesco
    Sanguineti, Giuseppe
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (04): : 1088 - 1088
12345